↓ Skip to main content

Outcome and death risk of diabetes patients with Covid-19 receiving pre-hospital and in-hospital metformin therapies

Overview of attention for article published in Diabetology & Metabolic Syndrome, July 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users

Citations

dimensions_citation
25 Dimensions

Readers on

mendeley
85 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Outcome and death risk of diabetes patients with Covid-19 receiving pre-hospital and in-hospital metformin therapies
Published in
Diabetology & Metabolic Syndrome, July 2021
DOI 10.1186/s13098-021-00695-8
Pubmed ID
Authors

Rodrigo Esaki Tamura, Said Muhammad Said, Leticia Mussin de Freitas, Ileana Gabriela Sanchez Rubio

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 85 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 85 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 9 11%
Researcher 8 9%
Student > Master 5 6%
Other 5 6%
Lecturer 2 2%
Other 9 11%
Unknown 47 55%
Readers by discipline Count As %
Medicine and Dentistry 13 15%
Biochemistry, Genetics and Molecular Biology 6 7%
Nursing and Health Professions 5 6%
Immunology and Microbiology 3 4%
Agricultural and Biological Sciences 2 2%
Other 8 9%
Unknown 48 56%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 July 2022.
All research outputs
#15,379,760
of 22,880,230 outputs
Outputs from Diabetology & Metabolic Syndrome
#368
of 670 outputs
Outputs of similar age
#250,248
of 433,487 outputs
Outputs of similar age from Diabetology & Metabolic Syndrome
#6
of 12 outputs
Altmetric has tracked 22,880,230 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 670 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.1. This one is in the 35th percentile – i.e., 35% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 433,487 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 32nd percentile – i.e., 32% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.